Paper33765691
Endothelin receptor antagonists for pulmonary arterial hypertension.
Liu C and 4 others. Cochrane Database Syst Rev, 2021. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Endothelin receptor antagonists for pulmonary arterial hypertension. Papers, record 33765691. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33765691
- Disease
- systemic sclerosis114 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review
- PubMed
Connected records3
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antihypertensive Agents | Major topic |
| Endothelin Receptor Antagonists | Major topic |
| Hypertension, Pulmonary | Major topic |
| Bias | |
| Humans | |
| Phosphodiesterase 5 Inhibitors | |
| Randomized Controlled Trials as Topic | |
| Walk Test |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00070590 | Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT00077584 | Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma | Derived from the trial | Yes | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 23450552 | Endothelin receptor antagonists for pulmonary arterial hypertension. | https://conductscience.org/library/papers/23450552 |
Source PubMed
References115
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18831711 | Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension. | Clin Sci (Lond) | 2009 | https://conductscience.org/library/papers/18831711 | PubMed |
| 2 | 24524605 | [Efficacy of endothelin receptor antagonist bosentan on the long-term prognosis in patients after Fontan operation]. | Zhonghua Xin Xue Guan Bing Za Zhi | 2013 | https://conductscience.org/library/papers/24524605 | PubMed |
| 3 | 20581169 | Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy. | Am J Respir Crit Care Med | 2010 | https://conductscience.org/library/papers/20581169 | PubMed |
| 4 | 15593188 | Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. | Arthritis Rheum | 2004 | https://conductscience.org/library/papers/15593188 | PubMed |
| 5 | 12706935 | Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. | J Am Coll Cardiol | 2003 | https://conductscience.org/library/papers/12706935 | PubMed |
| 6 | 16793845 | Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions. | Ann Rheum Dis | 2006 | https://conductscience.org/library/papers/16793845 | PubMed |
| 7 | 20506355 | Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis. | Arthritis Rheum | 2010 | https://conductscience.org/library/papers/20506355 | PubMed |
| 8 | 21256048 | Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension. | J Heart Lung Transplant | 2011 | https://conductscience.org/library/papers/21256048 | PubMed |
| 9 | 22723290 | The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension. | Am J Respir Crit Care Med | 2012 | https://conductscience.org/library/papers/22723290 | PubMed |
| 10 | 24293470 | Pathogenesis of pulmonary arterial hypertension: lessons from cancer. | Eur Respir Rev | 2013 | https://conductscience.org/library/papers/24293470 | PubMed |
| 11 | 19095129 | Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. | J Am Coll Cardiol | 2008 | https://conductscience.org/library/papers/19095129 | PubMed |
| 12 | 25405182 | The role of endothelin-1 in pulmonary arterial hypertension. | Glob Cardiol Sci Pract | 2014 | https://conductscience.org/library/papers/25405182 | PubMed |
| 13 | 9727772 | Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. | Eur Respir J | 1998 | https://conductscience.org/library/papers/9727772 | PubMed |
| 14 | 16982941 | Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. | Circulation | 2006 | https://conductscience.org/library/papers/16982941 | PubMed |
| 15 | 28233631 | Comparative efficacy and acceptability of endothelin receptor antagonists for pulmonary arterial hypertension: A network meta-analysis. | Int J Cardiol | 2017 | https://conductscience.org/library/papers/28233631 | PubMed |
| 16 | 15601804 | Comparative investigation of the pharmacokinetics of bosentan in Caucasian and Japanese healthy subjects. | J Clin Pharmacol | 2005 | https://conductscience.org/library/papers/15601804 | PubMed |
| 17 | 30957635 | Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH). | Pulm Circ | 2019 | https://conductscience.org/library/papers/30957635 | PubMed |
| 18 | 23523254 | Tezosentan and right ventricular failure in patients with pulmonary hypertension undergoing cardiac surgery: the TACTICS trial. | J Cardiothorac Vasc Anesth | 2013 | https://conductscience.org/library/papers/23523254 | PubMed |
| 19 | 9692778 | Systemic and renal effects of an ET(A) receptor subtype-specific antagonist in healthy subjects. | Br J Pharmacol | 1998 | https://conductscience.org/library/papers/9692778 | PubMed |
| 20 | 18572079 | Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. | Lancet | 2008 | https://conductscience.org/library/papers/18572079 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42948525 | Machine learning, molecular docking, and experimental validation identify shared molecular signatures between idiopathic pulmonary arterial hypertension and malignant pleural mesothelioma: a retrospective study. | Front Genet | 2026 | https://conductscience.org/library/papers/42948525 | PubMed |
| 42172221 | Exploratory research on drugs after lung surgery based on real-world data from the FDA adverse event reporting system database. | PLoS One | 2026 | https://conductscience.org/library/papers/42172221 | PubMed |
| 41363010 | Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension. | Hypertension | 2026 | https://conductscience.org/library/papers/41363010 | PubMed |
| 41309270 | Impact of positive airway pressure therapy on pulmonary arterial pressures in obstructive sleep apnoea or obesity hypoventilation syndrome: a systematic review and meta-analysis. | Eur Respir J | 2026 | https://conductscience.org/library/papers/41309270 | PubMed |
| 41031504 | Endothelin: A Potential Universal Systemic Biomarker. | Curr Med Chem | 2026 | https://conductscience.org/library/papers/41031504 | PubMed |
| 40757552 | Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension. | Cochrane Database Syst Rev | 2025 | https://conductscience.org/library/papers/40757552 | PubMed |
| 40724982 | Pulmonary Embolism in Acute Ischaemic Stroke: Evolving Evidence, Diagnostic Challenges, and a Novel Thromboinflammatory Axis Hypothesis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40724982 | PubMed |
| 40601167 | Endothelin Receptor Antagonists for the Treatment of Hypertension: Recent Data from Clinical Trials and Implementation Approach. | Curr Cardiol Rep | 2025 | https://conductscience.org/library/papers/40601167 | PubMed |
| 40358683 | Repurposing of modafinil as an anti-inflammatory drug: a systematic review of experimental studies. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40358683 | PubMed |
| 39995630 | Sotatercept: A First-In-Class Activin Signaling Inhibitor for Pulmonary Arterial Hypertension. | J Pharm Technol | 2025 | https://conductscience.org/library/papers/39995630 | PubMed |
| 39897541 | Shear stress unveils patient-specific transcriptional signatures in PAH: Towards personalized molecular diagnostics. | Theranostics | 2025 | https://conductscience.org/library/papers/39897541 | PubMed |
| 39866113 | 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. | Circulation | 2025 | https://conductscience.org/library/papers/39866113 | PubMed |
| 39684535 | Complement Immune System in Pulmonary Hypertension-Cooperating Roles of Circadian Rhythmicity in Complement-Mediated Vascular Pathology. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684535 | PubMed |
| 39075075 | Structural basis of antagonist selectivity in endothelin receptors. | Cell Discov | 2024 | https://conductscience.org/library/papers/39075075 | PubMed |
| 39023895 | Removing the FDA's Boxed Hepatotoxicity Warning and Liver Function Testing Requirement for Ambrisentan. | JAMA Netw Open | 2024 | https://conductscience.org/library/papers/39023895 | PubMed |
| 38555425 | Novel insights and new therapeutic potentials for macrophages in pulmonary hypertension. | Respir Res | 2024 | https://conductscience.org/library/papers/38555425 | PubMed |
| 38366267 | Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study. | Eur J Pediatr | 2024 | https://conductscience.org/library/papers/38366267 | PubMed |
| 38264914 | 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. | Circulation | 2024 | https://conductscience.org/library/papers/38264914 | PubMed |
| 38195688 | The underlying mechanisms of DNA methylation in high salt memory in hypertensive vascular disease. | Sci Rep | 2024 | https://conductscience.org/library/papers/38195688 | PubMed |
| 37443671 | Could Endothelin-1 Be a Promising Neurohormonal Biomarker in Acute Heart Failure? | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/37443671 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PDE5A | 8654 | PubTator's text mining | https://conductscience.org/library/genes/8654 |
Source NCBI Gene
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| BOSENTAN | CHEMBL957 | Derived from the trial | 2 | https://conductscience.org/library/drugs/CHEMBL957 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33765691
GET https://conductscience.org/api/papers/v1/33765691/references?page=2